Table of Contents
What is the impact factor of stem cell research Elsevier?
Following this calculation change, the 2020 Impact Factor of Stem Cell Research dropped from 4.489 to 2.020. The journal’s impact factor has risen each year, from 1.82 in 2014 to 8.890 in 2021; the 5-year impact factor is 9.620. It is published by Wiley-Blackwell. The overall rank of Stem Cells is 2447. According to SCImago Journal Rank (SJR), this journal is ranked 1.374. The overall rank of Stem Cell Research and Therapy is 2585. According to SCImago Journal Rank (SJR), this journal is ranked 1.33. SCImago Journal Rank is an indicator, which measures the scientific influence of journals.
What is the impact factor of stem cell international?
The 2022-2023 Journal’s Impact IF of Stem Cells International is 5.443, which is just updated in 2023. Decades of research has allowed us to glimpse the potential of stem cells to treat disease. It is possible they will give us life-changing therapies for multiple sclerosis, type 1 diabetes, Parkinson’s disease and macular degeneration, amongst others. The stem cell controversy is the consideration of the ethics of research involving the development and use of human embryos. Most commonly, this controversy focuses on embryonic stem cells. Not all stem cell research involves human embryos. In 2001, President George W. Bush banned federal funding for embryonic stem cell research, citing that the use of these embryos, which would otherwise be discarded or would deteriorate in long-term storage, diminishes the value of human life. However, human embryonic stem cell (hESC) research is ethically and politically controversial because it involves the destruction of human embryos. In the United States, the question of when human life begins has been highly controversial and closely linked to debates over abortion. Cell Stem Cell Rank and SCImago Journal Rank (SJR) The overall rank of Cell Stem Cell is 111. According to SCImago Journal Rank (SJR), this journal is ranked 7.935. SCImago Journal Rank is an indicator, which measures the scientific influence of journals.
What is the impact factor of stem cells 2022?
The 2022-2023 Journal’s Impact IF of Stem Cells is 6.277, which is just updated in 2023. The 2022-2023 Journal’s Impact IF of PLoS ONE is 3.24, which is just updated in 2023. Stanford has been a leader in stem cell research for the past three decades. Stem cell research holds promise for generating breakthroughs against conditions including Alzheimer’s, cancer, diabetes, heart disease, vision loss—and even COVID-19. Yet this leading-edge science requires significant investment, much of which may need to come from public funding sources.
What is the impact factor of stem cell res ther 2022?
The 2022-2023 Journal’s Impact IF of Stem Cell Research and Therapy is 5.985, which is just updated in 2023. The journal’s impact factor has risen each year, from 1.82 in 2014 to 8.890 in 2021; the 5-year impact factor is 9.620. Opponents argue that the research is unethical, because deriving the stem cells destroys the blastocyst, an unimplanted human embryo at the sixth to eighth day of development. As Bush declared when he vetoed last year’s stem cell bill, the federal government should not support “the taking of innocent human life.” Currently, the only stem cell treatments approved by the Food and Drug Administration (FDA) are products that treat certain cancers and disorders of the blood and immune system. Use of stem cells for any other purpose outside the domain of clinical trials will be considered unethical and hence is not permissible. Use of stem cells for any other purpose outside the domain of clinical trials will be considered unethical and hence is not permissible.
What is the impact factor of cell stem cells 2022?
The 2022-2023 Journal’s Impact IF of Cell Stem Cell is 24.633, which is just updated in 2023. The 2022-2023 Journal’s Impact IF of Stem Cells is 6.277, which is just updated in 2023. The 2022-2023 Journal’s Impact IF of PLoS ONE is 3.24, which is just updated in 2023. The overall rank of Stem Cells is 2447. According to SCImago Journal Rank (SJR), this journal is ranked 1.374. Decades of research has allowed us to glimpse the potential of stem cells to treat disease. It is possible they will give us life-changing therapies for multiple sclerosis, type 1 diabetes, Parkinson’s disease and macular degeneration, amongst others. These unproven, unregulated stem cell treatments carry significant risk. The risks range from administration site reactions to dangerous adverse events. For example, injected cells can multiply into inappropriate cell types or even dangerous tumors.
Is stem cell research growing?
Stem cell research is growing twice as fast (7%) as the world average growth in research (2.9%). In the area of induced pluripotent stem cells, the annual growth rate since 2008 is 77%. Cons of the stem cell therapy include: Adult stem cells are hard to grow for long period in culture. There is still no technology available to generate adult stem cells in large quantities. Stimulated pluripotent cells normally do not have any p method of maintenance and reproducibility. What is the average cost of stem cell therapy? The average cost of stem cell therapy ranges from under $5,000 to over $25,000, depending the type and sources of the stem cells, the patient’s medical condition, and the number of treatments required. Stem cell research is legal in the United States, however, there are restrictions on its funding and use. Currently, the only stem cells now used to treat disease are from blood cell-forming adult stem cells found in bone marrow.